Analysis of wilms tumors using SNP mapping array-based comparative genomic hybridization

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Hawthorn, Lesleyann ^a   Cowell, John K ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE;

ARTICLE; CANCER STAGING; CHILD; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 12; CHROMOSOME 14Q; CHROMOSOME 16Q; CHROMOSOME 18; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 21Q; CHROMOSOME 4Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8; CHROMOSOME 9Q; CHROMOSOME DELETION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA MICROARRAY; GENE MAPPING; GENETIC GAIN; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KARYOTYPE; NEPHROBLASTOMA; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; IN VITRO STUDY; KARYOTYPING; METHODOLOGY;

COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; KARYOTYPING; LOSS OF HETEROZYGOSITY; POLYMORPHISM, SINGLE NUCLEOTIDE; WILMS TUMOR;

EID: 79955530313     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018941     Document Type: Article

References (60)

1. Stiller CA, Parkin DM, (1990) International variations in the incidence of childhood renal tumours. Br J Cancer 62: 1026-1030.
2. Beckwith JB, Kiviat NB, Bonadio JF, (1990) Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol 10: 1-3.
3. Breslow NE, Olson J, Moksness J, Beckwith JB, Grundy P, (1996) Familial Wilms' tumor: a descriptive study. Med Pediatr Oncol 27: 398-440.
4. McDonald JM, Douglass EC, Fisher R, Geiser CF, Krill CE, et al. (1998) Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res 58: 1387-1390.
5. Rahman N, Arbour L, Tonin P, Renshaw J, Pelletier J, et al. (1996) Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21. Nat Genet 13: 461-463.
6. Scott RH, Stiller CA, Walker L, Rahman N, (2006) Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour. J Med Genet 43: 705-715.
7. Riccardi VM, Sujansky E, Smith AC, Francke U, (1978) Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics 61: 604-610.
8. Denys P, Malvaux P, Van Den Berghe H, Tanghe W, Proesmans W, (1967) Association of an anatomo-pathological syndrome of male pseudohermaphroditism,Wilms' tumor, parenchymatous nephropathy and XX/XY mosaicism. Arch Fr Pediatr 24: 729-733.
9. Drash A, Sherman F, Hartmann WH, Blizzard RM, (1970) A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension, and degenerative renal disease. J Pediatr 76: 585-593.
10. Grundy RG, Pritchard J, Baraitser M, Risdon A, Robards M, (1992) Perlman and Wiedemann-Beckwith syndromes: two distinct conditions associated with Wilms' tumour. Eur J Pediatr 151: 895-898.
11. Wiedemann HR, (1964) Familial malformation complex with umbilical hernia and macroglossia-a "new syndrome"? J Genet Hum 13: 223-232.
12. Beckwith JB, (1969) Macroglossia, omphalocele, adrenal cytomegaly. Gigantism and hyperplastic visceromegaly. Birth Defects 5: 188-196.
13. Coppes MJ, de Kraker J, van Dijken PJ, Perry HJ, Delemarre JF, et al. (1989) Bilateral Wilms' tumor: long-term survival and some epidemiological features. J Clin Oncol 7: 310-315.
14. Knudson AG, (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci 68: 820-823.
15. Knudson AG, Strong LC, (1972) Mutation and cancer: a model for Wilms' tumor of the kidney. J Natl Cancer Inst 48: 313-324.
16. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, et al. (1993) WT-1 is required for early kidney development. Cell 74: 679-691.
17. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, et al. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60: 509-520.
18. Narahara K, Kikkawa K, Kimira S, Kimoto H, Ogata M, et al. (1984) Regional mapping of catalase and Wilms tumor-aniridia, genitourinary abnormalities, and mental retardation triad loci to the chromosome segment 11p1305-p1306. Hum Genet 66: 181-185.
19. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, et al. (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779-784.
20. Mannens M, Slater RM, Heyting C, Bliek J, de Kraker J, et al. (1988) Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours. Hum Genet 81: 41-48.
21. Wadey RB, Pal NP, Buckle B, Yeomans E, Pritchard J, et al. (1990) Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11. Oncogene 5: 901-907.
22. Mannens M, Hoovers JMN, Redeker E, Vergjaal M, Feinberg AP, et al. (1994) Parental imprinting of human chromosome region 11p15.3-pter involved in the Beckwith-Wiedemann syndrome and various human neuoplasia. Eur J Hum Genet 41: 1-22.
23. Grundy RG, Aledo R, Cowell JK, (1998) Characterization of the breakpoints in unbalanced t(5;11)(p15;p15) constitutional chromosome translocations in two patients with Beckwith-Wiedemann syndrome using Fluorescence in situ Hybridisation. Int J Molec Med 1: 801-808.
24. Weksberg R, Shuman C, Beckwith JB, (2010) Beckwith-Wiedemann syndrome. Eur J Hum Genet 18: 8-14.
25. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, et al. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362: 749-755.
26. Baird PN, Groves N, Haber DA, Housman DE, Cowell JK, (1992) Identification of mutations in the WT1 gene in tumors from patients with the WAGR syndrome. Oncogene 7: 2141-2149.
27. Cowell JK, Wadey RB, Haber DA, Call, KM, Housman DE, et al. (1991) Structural rearrangements of the WT1 gene in Wilms' tumour cells. Oncogene 6: 595-599.
28. Slater RM, Mannens MM, (1992) Cytogenetics and molecular genetics of Wilms' tumor of childhood. Cancer Genet Cytogenet 61: 111-112.
29. Solis V, Pritchard J, Cowell JK, (1988) Cytogenetic changes in Wilms' tumors. Cancer Genet Cytogenet 34: 223-234.
30. Getman ME, Houseal TW, Miler GA, Grundy P, Cowell JK, et al. (1998) Comparative genomic hybridization and its application to Wilms tumorigenesis. Cytogenet. Cell Genet 82: 284-290.
31. Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, et al. (1992) A third Wilms' tumor locus on chromosome 16q. Cancer Res 52: 3094-3098.
32. Cowell, JK, Nowak NJ, (2003) High resolution analysis of genetic events in cancer cells using BAC arrays and CGHa. Adv Cancer Res 90: 91-125.
33. Cowell, JK, Hawthorn L, (2008) The Application of Microarray Technology to the Analysis of the Cancer Genome. Current Molecular Medicine 7: 103-120.
34. Natrajan R, Little SE, Sodha N, Reis-Filho JS, Mackay A, et al. (2007) Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour. J Pathol 211: 52-59.
35. Yuan E, Li CM, Yamashiro DJ, Kandel J, Thaker H, et al. (2005) Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors. Mol Cancer Res 3: 493-502.
36. Lo KC, Bailey D, Burkhardt T, Gardina P, Turpaz Y, et al. (2008) Comprehensive analysis of loss of heterozygosity events in glioblastoma using the 100K SNP mapping arrays and comparison with copy number abnormalities defined by BAC array comparative genomic hybridization. Genes Chroms Cancer 47: 221-237.
37. Cowell JK, Lo KC, (2009) Application of oligonucleotides arrays for coincident comparative genomic hybridization, ploidy status and loss of heterozygosity studies in human cancers. Methods in Mol Biol 556: 47-65.
38. Gardina PJ, Lo KC, Lee W, Cowell JK, Turpaz Y, (2008) Ploidy status and copy number aberrations in primary glioblastomas defined by integrated analysis of allelic ratios, signal ratios and loss of heterozygosity on 500K SNP Mapping Arrays. BMC Genomics 9: 489-503.
39. Ried T, Heselmeyer-Haddad K, Blegen H, Schröck E, Auer G, (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25: 195-204.
40. Hing S, Lu YJ, Summersgill B, King-Underwood L, Nicholson J, et al. (2001) Gain of 1q is associated with adverse outcome in favorable histology Wilms' tumors. Am J Pathol 158: 393-398.
41. Grundy RG, Pritchard J, Scambler P, Cowell JK, (1998) Loss of Heterozygosity on chromosome 16 in Sporadic Wilms tumour. Br J Cancer 78: 1181-1187.
42. Safford SD, Goyeau D, Freemerman AJ, Bentley R, Everett ML, et al. (2003) Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases. Ann Surg Oncol 1: 136-143.
43. Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, et al. (1994) Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 54: 2331-2333.
44. Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, et al. (2005) Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23: 7312-7321.
45. Messahel B, Williams R, Ridolfi A, A'hern R, Warren W, et al. (2009) Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study. Eur J Cancer 45: 819-826.
46. Grundy RG, Pritchard J, Scambler P, Cowell JK, (1998) Loss of Heterozygosity for the short arm of Chromosome 7 in Sporadic Wilms tumour. Oncogene 17: 395-400.
47. Sossey-Alaoui K, Vieira L, David D, Boavida MG, Cowell JK, (2003) Molecular Characterization of a 7p15-21 Homozygous Deletion in a Wilms Tumor. Genes, Chromosome and Cancer 36: 1-6.
48. Ruteshouser EC, Hendrickson BW, Colella S, Krahe R, Pinto L, et al. (2005) Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors. Genes Chromosomes Cancer 43: 172-180.
49. Williams RD, Al-Saadi R, Chagtai T, Popov S, Messahel B, et al. (2010) Subtype-specific FBXW7 mutation and MYCN copy number gain in Wilms' tumor. Clin Cancer Res 16: 2036-2045.
50. Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, et al. (1994) Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet 7: 91-97.
51. Bown N, Cotterill SJ, Roberts P, Griffiths M, Larkins S, et al. (2002) Cytogenetic abnormalities and clinical outcome in Wilms tumor: a study by the U.K. cancer cytogenetics group and the U.K. Children's Cancer Study Group. Med Pediatr Oncol 38: 11-21.
52. Gessler M, König A, Arden K, Grundy P, Orkin S, et al. (1994) Infrequent mutation of the WT1 gene in 77 Wilms' Tumors. Hum Mutat 3: 212-222.
53. Wittmann S, Zirn B, Alkassar M, Ambros P, Graf N, et al. (2007) Loss of 11q and 16q in Wilms tumors is associated with anaplasia, tumor recurrence, and poor prognosis. Genes Chroms Cancer 46: 163-170.
54. Kaneko Y, Homma C, Maseki N, Sakurai M, Hata J, (1991) Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. Cancer Res 51: 5937-5942.
55. Yeh A, Wei M, Golub SB, Yamashiro DJ, Murty VV, et al. (2002) Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene. Genes Chroms Cancer 35: 156-163.
56. Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, et al. (1999) Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 59: 3880-3882.
57. Affymetrix: BRLMM: an Improved Genotype Calling Method for the GeneChip® Human Mapping 500K Array Set: [http://www.affymetrix.com/support/technical/whitepapers/brlmm_whitepaper.pdf, 2006.]. Accessed 2011 April 4.
58. Affymetrix: apt-copynumber-pipeline: [http://www.affymetrix.com/support/developer/tools/devnettools.affx, 2008.]. Accessed 2011 April 4.
59. Affymetrix: CNAT 4.0: Copy Number and Loss of Heterozygosity Estimation Algorithms for the GeneChip® Human Mapping 10/50/100/250/500K Array Set: [http://www.affymetrix.com/support/technical/whitepapers/cnat_4_algorithm_whitepaper.pdf, 2007.]. Accessed 2011 April 4.
60. Shankar G, Rossi MR, McQuaid D, Conroy JM, Gaile DG, et al. (2006) aCGH viewer: A generic visualization tool for aCGH data. Cancer Informatics 2: 36-43.